Lunar reports higher sales, profits

Article

Lunar continues to post improvingfinancial numbers. The Madison, WI, company last month reportedsharply higher results for the third quarter of 1994 (end-March). Total revenues for the quarter increased 21%, to $8 millionfrom $6.6 million in the same

Lunar continues to post improvingfinancial numbers. The Madison, WI, company last month reportedsharply higher results for the third quarter of 1994 (end-March).

Total revenues for the quarter increased 21%, to $8 millionfrom $6.6 million in the same period the year before. Net incomefor the quarter jumped 73%, to $2 million compared to $1.2 millionin the second quarter of 1993. The jump in Lunar's financial resultsis due to strong sales of its Achilles line, according to thecompany.

While Achilles is surging, Lunar reported that it has experienceddelays in finalizing the system integration of hardware and softwarefor its Expert high-end bone densitometry system. While severalbeta sites have been successfully installed, the company doesnot expect extensive shipments of Expert during the current fiscalyear.

Lunar is also the exclusive North American distributor forEsaote Biomedica's Artoscan niche MRI system.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.